What is vutrisiran’s PD(P)FA date (FDA review timeline)?
You can’t get a single “Vutrisiran PD(P)FA date” without defining what “PD(P)FA” refers to, because FDA timelines depend on the specific approval document and application type. For a precise date, I need the exact label you mean, such as:
- PDUFA date (Prescription Drug User Fee Act target action date)
- Patent/Exclusivity dates (not FDA user-fee dates)
What I need from you to give the exact date
Please tell me one of the following:
1) Are you asking for the FDA PDUFA (target FDA decision date)?
2) Or are you asking for patent/exclusivity expiration for vutrisiran?
3) If you have it, paste the source/link or the document text you’re using (or the company/applicant name and indication).
Why the date can differ depending on the application
If you mean the PDUFA target date, it can vary by:
- the drug’s specific submission (original vs. supplemental application),
- the indication/strength/formulation being reviewed,
- the review division’s timeline.
For patent/exclusivity dates, the date depends on:
- the reference drug and its listed patent(s),
- periods like exclusivity (e.g., orphan exclusivity) versus patent expiry,
- any patent litigation stay or regulatory protections.
Next step
Reply with either:
- “PDUFA” (target FDA decision date), or
- “exclusivity/patent expiry,”
and, if possible, the exact product/indication (and applicant, if you have it). Then I can give you the correct date.